Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000755966 | SCV000883655 | likely benign | not provided | 2018-02-27 | criteria provided, single submitter | clinical testing | The c.4650A>T; p.Pro1550Pro variant (rs778312075) does not alter the amino acid sequence of the COL5A1 protein and computational splice site prediction algorithms do not predict a change in the nearest splice site or creation of a cryptic splice site. This variant has not been reported in association with Ehlers-Danlos syndrome in medical literature or in gene specific variation databases. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.001% (identified on 3 out of 277,214 chromosomes). Based on the available information, the c.4650A>T variant is likely to be benign. |
Labcorp Genetics |
RCV002233747 | SCV001633622 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000755966 | SCV001962595 | likely benign | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027121 | SCV005032402 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-11-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |